Propionic Acid Topical Compositions for Eczema Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for atopic dermatitis (AD) are limited by the rapid recurrence of S. aureus colonization, antibiotic resistance, and side effects from long-term use of antibiotics and topical corticosteroids, which do not effectively manage the disease's inflammatory and toxic effects while minimizing recurrence and side effects.
Innovation Solution
Topical compositions and methods utilizing propionic acid and its non-steroidal derivatives, prepared through fermentation or chemical synthesis, combined with other active pharmaceutical ingredients like corticosteroids, antibiotics, and immunomodulators, to reduce S. aureus colonization and inflammation, thereby addressing the disease's symptoms and recurrence.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If long-term antibiotic treatment is used to reduce S. aureus colonization, then bacterial load is reduced, but antibiotic resistance develops
Solution Approach 1:
The patent combines multiple active ingredients with different mechanisms of action (antibiotics, corticosteroids, immunomodulators, antiseptics) into a single topical composition. This multi-functional approach allows simultaneous bacterial reduction, inflammation control, and immune modulation, reducing reliance on any single antibiotic and thereby slowing resistance development.
Solution Approach 2:
The invention uses composite formulations containing multiple pharmacologically active substances working synergistically. The combination includes antibiotics for bacterial killing, corticosteroids for anti-inflammatory effects, immunomodulators for immune system regulation, and antiseptics for surface disinfection. This composite approach addresses multiple disease aspects simultaneously while reducing the need for high-dose monotherapy.
2Reliability
If topical corticosteroids are used to reduce inflammation, then inflammatory symptoms are improved, but side effects increase with long-term use
Solution Approach 1:
The patent merges corticosteroids with immunomodulators and antiseptics in a single formulation. The immunomodulators (such as calcineurin inhibitors) provide alternative anti-inflammatory pathways that may reduce corticosteroid dependency. The antiseptics address the underlying S. aureus colonization that drives inflammation, potentially allowing for reduced corticosteroid dosing and duration.
Solution Approach 2:
The formulation introduces immunomodulators as intermediary substances that mediate the immune response independently of corticosteroids. These immunomodulators can suppress inflammatory pathways through different mechanisms, serving as intermediaries that reduce reliance on corticosteroids and thereby minimize their side effects while maintaining anti-inflammatory effectiveness.
3Duration of action of stationary object
If frequent treatment applications are used to prevent disease recurrence, then disease-free periods are extended, but treatment complexity increases
Solution Approach 1:
The single topical composition performs multiple therapeutic functions simultaneously: antibacterial, anti-inflammatory, immunomodulatory, and antiseptic activities. This multi-functionality allows the treatment to address all aspects of atopic dermatitis pathology in one application, simplifying the treatment regimen while maintaining effectiveness in preventing recurrence.
Solution Approach 2:
The patent combines multiple treatment modalities into a single unified formulation that can be applied once or twice daily. This merging of multiple therapeutic approaches (antibiotic, steroid, immunomodulator, antiseptic) into one product simplifies patient compliance and reduces the complexity of managing multiple separate medications with different application schedules.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of propionic acid and its derivatives in topical compositions significantly reduces S. aureus overgrowth, inflammation, and disease recurrence, providing faster-acting and less side-effect-intensive treatments that manage AD symptoms more efficiently, including reducing itching and improving skin health.
Implementation Method 1
propionic acid is prepared by fermentation of P. acnes
Data Source
AI summary
Disclosed are compositions, methods of treatment using the compositions and methods of preparing the compositions for the treatment of eczema. The compositions may include propionic acid and/or non-steroidal esters of propionic acid. The compositions may further include a corticosteroid, immunomodulator, antibiotic, antibody, colloidal oatmeal, conditioned media prepared by bacterial fermentation, short chain fatty acids, picolinic acid, or emollient. The method of treatment may include analysis of the skin microbiome.